Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with
adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and …

Objectives This study sought to evaluate the effects of empagliflozin on extracellular volume
(ECV) in individuals with type 2 diabetes mellitus (T2DM) and coronary artery disease …

The prevalence of heart failure (HF) is approximately 1–2% of the adult population in
developed countries, rising to≥ 10% among people over 70. The common symptoms of HF …

Background: The prognosis of patients with idiopathic dilated cardiomyopathy (DCM) has
improved remarkably in recent decades with guideline-directed medical therapy. Left …

Objective To investigate the prognostic significance of T1 mapping using T1 long and short
in hypertrophic cardiomyopathy (HCM) patients. Methods A total of 263 consecutive patients …

Background Cardiac fibrosis plays a crucial role in the pathogenesis of dilated
cardiomyopathy (DCM). HE4 (human epididymis protein 4) is a secretory protein expressed …

Purpose Radiation-induced cardiac toxicity is a potential lethal complication. The aim of this
study was to assess whether there is a dose-dependent relationship between radiation dose …

Aims To evaluate the prognostic value of left ventricular (LV) remodelling index (RI) in
idiopathic dilated cardiomyopathy (DCM) patients. Methods and results We prospectively …

Cardiotoxicity is a well-recognised side effect of cancer-related therapies with a great impact
on outcomes and quality of life in the cancer survivor population. The pathogenesis of …

Background Myocardial fibrosis and left ventricular (LV) longitudinal strain are
independently associated with adverse clinical outcomes. However, the relationship …